Odimma

Provider of immunotherapy for the cancer treatment

placeIllkirch Graffenstaden, Grand Est, France calendar_todayFounded 2017 groups8 employees language odimma-therapeutics.com

Social engagement

Social engagement: 1.2K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Capital Grand Est.

Investor typeCountShare
Private equity120%
Angel & family office240%
Accelerator & incubator120%
Bank & private debt120%

Recent activity

29 Aug 2025
Milestone
regulatory
Coming soon